Skip to content

Chemoreduction combined with partial exenteration for orbital retinoblastoma

Chemoreduction combined with partial exenteration for orbital retinoblastoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ORC-17013231
Enrollment
Unknown
Registered
2017-11-03
Start date
2008-07-01
Completion date
Unknown
Last updated
2017-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

retinoblastoma

Interventions

1:chemoreduction combined with partial exenteration

Sponsors

Ophthalmolagy of Xiangya Hospital Central South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Years to 4 Years

Inclusion criteria

Inclusion criteria: 1. From 2008 to 2010, children with retinoblastoma were treated with chemotherapy combined with partial exenteration; 2. Informed consent form signed by parents of the patients.;Inclusion criteria: 1. From 2008 to 2010, children with retinoblastoma were treated with chemotherapy combined with partial exenteration; 2. Informed consent form signed by parents of the patients.;Inclusion criteria: 1. From 2008 to 2010, children with retinoblastoma were treated with chemotherapy combined with partial exenteration; 2. Informed consent form signed by parents of the patients.;Inclusion criteria: 1. From 2008 to 2010, children with retinoblastoma were treated with chemotherapy combined with partial exenteration; 2. Informed consent form signed by parents of the patients.;Inclusion criteria: 1. From 2008 to 2010, children with retinoblastoma were treated with chemotherapy combined with partial exenteration; 2. Informed consent form signed by parents of the patients.

Exclusion criteria

Exclusion criteria: No;Exclusion criteria: No;Exclusion criteria: No;Exclusion criteria: No;Exclusion criteria: No

Design outcomes

Primary

MeasureTime frame
survial rate;

Countries

China

Contacts

Public ContactJia Tan;Jia Tan;Jia Tan;Jia Tan;Jia Tan ;;;;

Xiangya Hospital Central South University;Xiangya Hospital Central South University;Xiangya Hospital Central South University;Xiangya Hospital Central South University;Xiangya Hospital Central South University

jasmintj@126.com;jasmintj@126.com;jasmintj@126.com;jasmintj@126.com;jasmintj@126.com+86 13875860564;+86 13875860564;+86 13875860564;+86 13875860564;+86 13875860564

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026